Speaker illustration

Doctor Narek Tmoyan

National Medical Research Center of Cardiology, Moscow (Russian Federation)

Elevated lipoprotein(a) level predicts repeated peripheral revascularization

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Peripheral Vascular and Cerebrovascular Disease ePosters


Role of lipoprotein(a) and its autoantibodies in polyvascular atherosclerotic disease

Event: ESC Congress 2020

Topic: Biomarkers

Session: Risk Factors and Prevention ePosters


Obesity paradox, hyperlipoproteinemia(a), autotaxin concentration and stenotic atherosclerosis of different vascular territories

Event: ESC Congress 2019

Topic: Obesity

Session: Obesity


Lipoprotein(a) and clinical outcomes in patients after revascularization of peripheral arteries

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Advances in peripheral arterial disease


Elevated lipoprotein(a) as a predictor of peripheral artery diseases

Event: ESC Congress 2018

Topic: Lipids, Other

Session: Preventive cardiology / Lipids


Lipoprotein(a) is a marker of peripheral artery disease in the absence of coronary heart disease.

Event: ESC Congress 2017

Topic: Pathophysiology, epidemiology

Session: Vascular diseases


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb